(Q54110223)

24 May 2018

title

Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion. (English)

1 reference

24 May 2018

1 reference

Jian-Jun Ma

1

1 reference

24 May 2018

Ling-Min Kong

2

1 reference

24 May 2018

Cheng-Gong Liao

3

1 reference

24 May 2018

Xue Jiang

4

1 reference

24 May 2018

Yong Wang

5

1 reference

24 May 2018

Ting-Yi Bao

6

1 reference

24 May 2018

publication date

13 June 2012

1 reference

24 May 2018

published in

Medical Oncology

1 reference

24 May 2018

volume

29

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

page(s)

3306-3313

1 reference

24 May 2018

https://scigraph.springernature.com/pub.10.1007/s12032-012-0265-1

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Resistance to targeted therapy in renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

The notch and TGF-β signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Expression of NDRG2 in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0265-1

Renal cell carcinoma: molecularly targeted therapy

21 January 2018

1 reference

12 December 2020

NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression

1 reference

12 December 2020

[Clinical and etiopathogenetic role of plasminogen and metaloproteinase systems in the tumor growth. Pericellular proteolysis of extracellular matrix and tumor growth]

1 reference

12 December 2020

[Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]

1 reference

12 December 2020

Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development

1 reference

12 December 2020

[Serum levels of matrix metaloproteinase 2 (MMP-2), matrix metaloproteinase 9 (MMP-9) and tissue inhibitor of metaloproteinase 2 (TIMP-2) in children and adolescents with growth hormone deficiency]

1 reference

12 December 2020

10.1007/S12032-012-0265-1

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

22692967

1 reference

24 May 2018